ZINC FINGER NUCLEASE (ZFN) CLINICAL TRIALS

All | CRISPR-Cas | TALEN | MegaNuclease | megaTAL | CAS-CLOVER | Base Editor

Antibacterial

Blood

Cancer

Eye

Metabolic disorder

Mucopolysaccharidosis type II, MPS II, (2018-000192-33)
Sponsors:
Sangamo Therapeutics, Inc.
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Mucopolysaccharidosis I, MPS I, (2018-000206-28)
Sponsors:
Sangamo Therapeutics, Inc.
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Mucopolysaccharidosis II, MPS II, (NCT03041324)
Sponsors:
Sangamo Therapeutics Inc. 
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Mucopolysaccharidosis type I, MPS I, (NCT02702115)
Sponsors:
Sangamo Therapeutics Inc.
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III

Other genetic conditions

close
Search CRISPR Medicine